Jobs

AI-enabled reproducibility infrastructure to unlock commercial distribution of scientific innovations

Twelve is a carbon transformation company converting captured carbon dioxide into valuable chemicals, fuels, and other essential products. Their technology eliminates emissions by turning CO2 into essential products that are made from fossil fuels. They specialize in the fields of CO2 electrocatalysis and electrochemical reactor design.

Zymochem provides a carbon-efficient bio-manufacturing platform that converts renewable feedstocks into bio-based materials without compromising price, performance, scale, or sustainability while minimizing CO2 loss during production. It also accelerates a real-zero economy by relieving carbon emissions in product development, use, and end-of-life.

Parallel Bio develops tools that help in the discovery and development of immunotherapies to eliminate current barriers and create the fastest path to a drug that works. Parallel Bio's platform combines best-in-class human immune organoids with computational methods to generate unprecedented insights into human health and disease.

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases, revolutionizing diagnostics using cell mechanics and machine learning. The company was founded in 2013 by Ajay Shah and Dino Di Carlo and is based in San Francisco, California.

Reach Industries is a software development company that develops a platform to increase productivity and quality in labs.

We build sensory reasoning models that go beyond the human capacity. General Sense captures real-world chemical telemetry through neural decoding, unlocking the sensory data needed for complete world models.

EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.

Checkerspot is a category-defining biotechnology company designing fats and oils through precision fermentation. We develop functional lipids not easily or sustainably sourced from nature, providing market-ready ingredients critical to meeting nutritional needs at every phase of life. With our biology-driven, molecule-licensing platform, we enable our partners to meet growing consumer demand for healthier, more sustainable ingredients at commercially relevant scale and cost.

Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet. Modern Meadow’s proprietary Bio-Alloy and Bio-Farm technology application platforms harness the unique properties of tuned proteins to sustainably move the world away from petrochemical and animal-derived inputs without compromising on performance. These innovations can drop into any existing infrastructures for immediate scalable adoption in the materials, beauty, and other industries. Modern Meadow's close relationship with development partners and production facilities allows companies partnering with Modern Meadow to feel confident knowing our products are 100% traceable from Lab-to-Brand.

ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine. The company is driven by a mission to transform the lives of those living with chronic migraine.

Ecovative is a biomaterials company that provides mycelium-based packaging alternatives to polystyrene and plastics. It uses mushroom mycelium technology to grow materials that replace plastics, leather, meat, and other unsustainable products.